Format
Sort by

Send to:

Choose Destination

Search results

Items: 4

1.

Differential expression of anterior gradient gene AGR2 in prostate cancer.

Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L.

BMC Cancer. 2010 Dec 13;10:680. doi: 10.1186/1471-2407-10-680.

2.

CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.

True LD, Zhang H, Ye M, Huang CY, Nelson PS, von Haller PD, Tjoelker LW, Kim JS, Qian WJ, Smith RD, Ellis WJ, Liebeskind ES, Liu AY.

Mod Pathol. 2010 Oct;23(10):1346-56. doi: 10.1038/modpathol.2010.122. Epub 2010 Jun 18.

3.

Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.

Pascal LE, VĂȘncio RZ, Page LS, Liebeskind ES, Shadle CP, Troisch P, Marzolf B, True LD, Hood LE, Liu AY.

BMC Cancer. 2009 Dec 18;9:452. doi: 10.1186/1471-2407-9-452.

4.

Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.

Pascal LE, Goo YA, VĂȘncio RZ, Page LS, Chambers AA, Liebeskind ES, Takayama TK, True LD, Liu AY.

BMC Cancer. 2009 Sep 8;9:317. doi: 10.1186/1471-2407-9-317.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk